Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunoregulatory Therapy for 2019-nCoV-induced Severe Pneumonia Patients

NCT04268537 is registered in ClinicalTrials.gov with Southeast University, China as lead sponsor.

NCT NCT04268537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04268537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunoregulatory Therapy for 2019-nCoV-induced Severe Pneumonia Patients
Lead sponsor
Southeast University, China
Phase
Phase 2
Overall status
Unknown status
Start date
February 10, 2020
Completion date
October 31, 2020
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

2019 ncov, pd-1